UNSPSC 51391807: Hydroxyamphetamine hydrobromide

This classification denotes an adrenergic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59IG47SZ0E. European Medicines Agency schedules Hydroxyamfetamine hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02581MIG. Hydroxyamphetamine hydrobromide generally arises in the molecular formula C9H13NO.BRH. The term 'hydroxyamphetamine hydrobromide' is a U.S. Pharmacopeial Convention designation.

As of Q4 2014, HYDROXYAMPHETAMINE HYDROBROMIDE remains the US FDA Preferred Term for this commodity. Hydroxyamphetamine hydrobromide bears US NLM identifiers UMLS ID C0282278 and NCI Concept Code C47558. SMILES: OC1CCC(CC(N)C)CC1.

UNSPSC 51391807 Hydroxyamphetamine hydrobromide is a Commodity code that in practice captures pharmaceutical products procured by state and local health agencies, though recent posting activity under this specific code shows minimal volume. The single recent opportunity on file — Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems — indicates that health departments and community health organizations use this taxonomy slot for emergency medical countermeasures and harm-reduction supplies, including opioid-reversal agents and controlled-substance disposal systems rather than the narrow active pharmaceutical ingredient the code name suggests. The scope of work involves competitive bidding for pharmaceutical consumables with specific annual unit requirements, quarterly delivery schedules to designated health facilities, and compliance with federal workplace and immigration verification standards.

Seminole County, Florida represents the sole recent issuer under this code in the available dataset. The IFB 60459723LAS, posted June 30, 2026, with response deadline July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. Bidders were required to submit electronic proposals through the county's e-Procurement Portal, include all shipping and delivery costs, maintain workers' compensation and liability coverage, and comply with drug-free workplace certification and E-Verify requirements. The contract carried a two-year initial term with one-year renewal option and potential FEMA funding subject to federal environmental compliance. The narrow activity under this code suggests it may not be the primary taxonomy vector for naloxone and pharmaceutical-supply procurement across most state and local jurisdictions, or that the bulk of such opportunities are tagged under broader pharmaceutical or medical-supply family codes.